Expert Speak
Discover expert insights from the leading figures in the field of pathology
instruments across India
0
+
Blood tests/sec on Transasia instruments
0
+
Global presence in countries
0
+
Channel Partners
0
+
Expert Speak
"Little things matter and every little care can make a significant difference. The little mosquito bite, when ignored, can matter a lot. Effective management of malaria hinges upon timely detection. Rapid diagnostic tests are pivotal to detect malaria infections at the point of care for prompt initiation of treatment and contribute to effective disease surveillance and control efforts, ultimately saving lives and reducing transmission. Be aware & Take Care, Every Little Precaution Counts!"
Dr Ravi Gaur
Founder & Director - UNIDRG Specialty Labs (LLP), New Delhi
Chairman - Medical Advisory Committee, Unipath Spl Labs, Ahmedabad India
"Early diagnosis for thrombotic conditions allows for timely intervention and management, reducing the risk of complications associated with these disorders. D-dimer is a product of blood clot breakdown. Elevated D-dimer levels suggest ongoing or recent clot formation and breakdown. It's used to detect abnormal clotting, crucial in conditions like DVT and PE. D-dimer testing is often used in conjunction with other clinical findings and imaging studies for a comprehensive diagnosis."
Dr. Mamta Soni
Sr. Consultant & HOD, Department of Haematology & Clinical Pathology
Apollo Main Hospital, Chennai
"Timely cancer diagnosis is crucial for better outcomes and is a vital public health strategy globally. In-vitro diagnostics (IVD) plays a pivotal role in early detection by providing precise molecular insights through technologies like flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), and immunohistochemistry (IHC). The evolving landscape of IVD holds promise for even more advanced techniques, ensuring early detection remains a cornerstone in the fight against cancer. Embracing these innovations enhances our ability to diagnose and treat cancer at its earliest stages, ultimately advancing patient care."
Dr. Kunal Sehgal
Hematopathologist and Flow Cytometrist
Director, Sehgal Path Lab
"Emerging trends in pathology are pivotal in revolutionizing early detection and monitoring of kidney diseases, accentuating the significance of urinalysis analyzers and serum biomarkers. Alongside liquid biopsies and AI-driven diagnostics, these analyzers and biomarkers play a crucial role. They offer non-invasive yet precise methods for assessing renal health, providing valuable insights into kidney function and disease progression. Integrating these technologies with advanced pathology approaches enhances our ability to detect abnormalities early, tailor treatment strategies, and ultimately improve outcomes for patients with kidney disorders."
Dr. Deepa Dave
National Director – Operations Pathkind Diagnostics
Delhi, India
